Osaic Holdings’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-1,626
| Closed | -$54.4K | – | 8155 |
|
|
2026
Q1 | $54.4K | Sell |
1,626
-283
| -15% | -$11.1K | ﹤0.01% | 5139 |
|
|
2025
Q4 | $88.4K | Buy |
1,909
+386
| +25% | +$21.2K | ﹤0.01% | 4819 |
|
|
2025
Q3 | $103K | Buy |
1,523
+667
| +78% | +$49.5K | ﹤0.01% | 4746 |
|
|
2025
Q2 | $71.7K | Buy |
856
+423
| +98% | +$31.7K | ﹤0.01% | 4774 |
|
|
2025
Q1 | $30.9K | Sell |
433
-265
| -38% | -$12.9K | ﹤0.01% | 5059 |
|
|
2024
Q4 | $31.4K | Buy |
698
+194
| +38% | +$10.1K | ﹤0.01% | 5039 |
|
|
2024
Q3 | $25.4K | Sell |
504
-2
| -0.4% | -$96 | ﹤0.01% | 5220 |
|
|
2024
Q2 | $20.6K | Sell |
506
-548
| -52% | -$23.2K | ﹤0.01% | 5322 |
|
|
2024
Q1 | $45.1K | Buy |
1,054
+983
| +1,385% | +$44.5K | ﹤0.01% | 4821 |
|
|
2023
Q4 | $2.86K | Hold |
71
| – | – | ﹤0.01% | 6390 |
|
|
2023
Q3 | $2.1K | Sell |
71
-800
| -92% | -$4.84K | ﹤0.01% | 6614 |
|
|
2023
Q2 | $3.74K | Buy |
871
+800
| +1,127% | +$3.44K | ﹤0.01% | 6437 |
|
|
2023
Q1 | $152 | Hold |
71
| – | – | ﹤0.01% | 7295 |
|
|
2022
Q4 | $0 | Hold |
71
| – | – | ﹤0.01% | 7406 |
|
|
2022
Q3 | $0 | Sell |
71
-4
| -5% | -$10 | ﹤0.01% | 7487 |
|
|
2022
Q2 | $0 | Sell |
75
-128
| -63% | -$354 | ﹤0.01% | 7569 |
|
|
2022
Q1 | $767K | Hold |
203
| – | – | ﹤0.01% | 2818 |
|
|
2021
Q4 | $1K | Hold |
203
| – | – | ﹤0.01% | 7241 |
|
|
2021
Q3 | $3K | Hold |
203
| – | – | ﹤0.01% | 6763 |
|
|
2021
Q2 | $3K | Buy |
+203
| New | +$3.43K | ﹤0.01% | 6625 |
|
Osaic Holdings's SLNO Position: Q2 2026 in Review
Osaic Holdings sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 1,626 shares — an estimated $54.4K sold.
Osaic Holdings first reported a position in SLNO in Q2 2021 and held it in 20 quarters. The position peaked at $767K in Q1 2022. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.
- Osaic Holdings reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
- Osaic Holdings sold 1,626 Soleno Therapeutics shares in Q2 2026, an estimated $54.4K.
- Osaic Holdings first reported a position in Soleno Therapeutics in Q2 2021 and held it in 20 quarters.
- Osaic Holdings's Soleno Therapeutics position peaked at $767K in Q1 2022.
- 0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.
Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.